InterCure
Yahoo Finance • 2 months ago
InterCure secures up to NIS 54M financing
* InterCure (INCR [https://seekingalpha.com/symbol/INCR]) signed a binding term sheet [https://seekingalpha.com/pr/20558823-intercure-secures-nis-22-million-in-private-placement-financing-led-by-leading-pharma-focused] for a private plac... Full story
Yahoo Finance • 4 months ago
InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow
The Company reported over NIS 270 million in revenue, NIS 37 million in Net loss, NIS 47 million in Adjusted EBITDA and NIS 17 million in positive operating cash flow, reflecting strong resilience and consistent profitability, with a twelf... Full story
Yahoo Finance • 6 months ago
InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million
InterCure reports preliminary estimated revenue of NIS 265 million for 2025 and positive Adjusted EBITDA, marking its twelfth consecutive half-year of positive Adjusted EBITDA. Revenue for 2025 represents an increase of approximately 11%... Full story
Yahoo Finance • 10 months ago
InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements to Advance Cannabis Science and Pharmaceutical Innovation
Agreements formalize research partnership combining InterCure’s global pharmaceutical platform with Cannasoul’s world-class analytics and scientific innovation Collaboration comes amidst reports that the Trump administration is exploring... Full story
Yahoo Finance • 11 months ago
InterCure Reports First Half 2025 Results with NIS 130 Million in Revenue and Positive Operating Cash Flow
The Company reports NIS 130 million in revenue and NIS 12 million in positive operating cash flow, demonstrating resilience and sustained profitability with its eleventh consecutive half of positive Adjusted EBITDA amidst ongoing recovery... Full story
Yahoo Finance • 11 months ago
InterCure Enters Premium US Cannabis Market With ISHI Deal
InterCure Ltd. (NASDAQ:INCR) revealed on Friday that it will acquire Botanico Ltd., known as ISHI, in a move designed to strengthen its global cannabis portfolio and deliver entry into premium American cultivation technology and brand part... Full story
Yahoo Finance • 11 months ago
InterCure Announces Strategic Acquisition of ISHI, Unlocking Access to Premium U.S. Cannabis Technology and Brands
Acquisition of leading cannabis company marks major milestone in InterCure’s commercial expansion strategy, bringing access to premium American brands and state-of-the-art cultivation technologies Transaction comes as Trump administration... Full story
Yahoo Finance • 3 years ago
InterCure Provides an Update Regarding the Security Situation in Israel
NEW YORK, and HERZLIYA, Israel, Oct. 17, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading medical cannabis company in Israel and outside of North America, today... Full story
Yahoo Finance • 3 years ago
InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY
Achieved record revenues of NIS 209million ($75 million)1for the first half of 2023 Annualized revenue run rate of NIS 417million($149 million) Adjusted EBITDA2of NIS 30million($11 million) Generated NIS 35 million($13 million) cashfrom... Full story
Yahoo Finance • 3 years ago
InterCure Ltd. Announces Proposed Voluntary Delisting from the Toronto Stock Exchange and shall continue to be listed on the NASDAQ and TASE
NEW YORK and TORONTO and HERZLIYA, Israel, July 10, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the "Company"), announced today that its board of directors (“Board”) has... Full story
Yahoo Finance • 3 years ago
InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger
NEW YORK and TORONTO and HERZLIYA, Israel, June 09, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the "Company"), reports today that, further to the Company’s press release... Full story
Yahoo Finance • 3 years ago
InterCure to Participate in the Cowen 3rd Annual European Cannabis Conference
NEW YORK, TORONTO, and HERZLIYA, Israel, May 15, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure") today announced that Alexander Rabinovitch, CEO of InterCure, will participate... Full story
Yahoo Finance • 3 years ago
InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOY
Achieved record revenues of $40 million for the first quarter Annualized revenue run rate of $159 million Adjusted EBITDA(1) of $6 Million Strong balance sheet with over $45 million cash and Net current assets of over $72 million NEW Y... Full story
Yahoo Finance • 3 years ago
InterCure to Be Featured with Mike Tyson in an Exclusive Interview on Fox Business
NEW YORK and TORONTO and HERZLIYA, Israel, May 15, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) ("InterCure'' or the "Company"), the largest and fastest growing medical cannabis company outside of North America, is... Full story
Yahoo Finance • 3 years ago
InterCure Informs That An Application To Approve a Class Action Against 26 Cannabis Companies in Israel, Including InterCure, Was Filed to The Court In Israel
NEW YORK, TORONTO, and HERZLIYA, Israel, April 24, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading cannabis company outside of North America, ann... Full story
Yahoo Finance • 3 years ago
InterCure Ltd. Partners with TYSON 2.0 in Israel, Australia, United Kingdom, Germany and Other EU Countries
NEW YORK and TORONTO and HERZLIYA, Israel, April 20, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading cannabis company outside of North America, a... Full story
Yahoo Finance • 3 years ago
InterCure Reschedules 2022 Full Year Results Conference Call
NEW YORK, TORONTO, and HERZLIYA, Israel, April 03, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) announced today that it has rescheduled its previously annou... Full story
Yahoo Finance • 3 years ago
InterCure Announces Record Fourth Quarter and Fiscal Year End 2022 Results
Record fiscal year 2022 revenue of $150 million Record fiscal year 2022 Adjusted EBITDA* of $32million Record fiscal year 2022net income of $17million Generated $20 Million cash flow from operations Strong balance sheet with over$95mil... Full story
Yahoo Finance • 4 years ago
InterCure Files Lawsuit Against Cann Pharmaceuticals to Recover Funds Following Failed Merger
NEW YORK, TORONTO, and HERZLIYA, Israel, Feb. 14, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)(“InterCure” or the “Company”) the biggest and most profitable cannabis company outside of n... Full story
Yahoo Finance • 4 years ago
InterCure Announces the Termination of its Acquisition Agreement with Cann Pharmaceutical (dba Better)
NEW YORK and TORONTO and HERZLIYA, Israel, Feb. 01, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company") announces that, further to the merger agreement with Cann... Full story